{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:05:47Z","timestamp":1779314747543,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Joint Project of Chongqing Science and Technology Bureau and Health Commission","award":["2020NCPZX03"],"award-info":[{"award-number":["2020NCPZX03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16957-8","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T09:45:55Z","timestamp":1756201555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Joint surveillance and correlation analysis of antimicrobial resistance and consumption of seven targeted bacteria, 2017\u20132023"],"prefix":"10.1038","volume":"15","author":[{"given":"Qiao","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"16957_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci, F., Pezzotti, P. & Pantosti, A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 109, 309\u2013318 (2015).","journal-title":"Pathog Glob Health"},{"key":"16957_CR2","unstructured":"World Health Organization. Antimicrobial resistance. (2021). Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance (Accessed March 21, 2023)."},{"key":"16957_CR3","unstructured":"O\u2019Neill, J. Review on antimicrobial resistance. Tackling drug-resistant infections globally (2016). Available from: https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf (Accessed March 21, 2023)."},{"key":"16957_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2042098614554919","volume":"5","author":"C Llor","year":"2014","unstructured":"Llor, C. & Bjerrum, L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther. Adv. Drug Saf. 5, 229\u2013241 (2014).","journal-title":"Ther. Adv. Drug Saf."},{"key":"16957_CR5","unstructured":"World Health Organization. Monitoring and evaluation of the global action plan on antimicrobial resistance. (2019). Available from: https:\/\/www.who.int\/publications\/i\/item\/monitoring-and-evaluation-of-the-global-action-planon-antimicrobial-resistance (Accessed March 21, 2023)."},{"key":"16957_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3904\/kjim.2017.332","volume":"35","author":"B Kim","year":"2020","unstructured":"Kim, B., Hwang, H., Kim, J., Lee, M. J. & Pai, H. Ten-year trends in antibiotic usage at a tertiary care hospital in korea, 2004 to 2013. Korean J. Intern. Med. 35, 703\u2013713 (2020).","journal-title":"Korean J. Intern. Med."},{"key":"16957_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jiph.2017.09.021","volume":"11","author":"H Wushouer","year":"2018","unstructured":"Wushouer, H. et al. Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur autonomous region, china: based on a 3 year surveillance data, 2014\u2013 2016. J. Infect. Public. Health. 11, 339\u2013346 (2018).","journal-title":"J. Infect. Public. Health"},{"key":"16957_CR8","first-page":"e13719","volume":"97","author":"B Kim","year":"2018","unstructured":"Kim, B. et al. Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in korea, 2004 to 2012: A nationwide multicenter study. Medicine (United States). 97, e13719 (2018).","journal-title":"Medicine (United States)"},{"key":"16957_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12879-020-04981-0","volume":"20","author":"B Yang","year":"2020","unstructured":"Yang, B. et al. Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014. BMC Infect. Dis. 20, 269 (2020).","journal-title":"BMC Infect. Dis."},{"key":"16957_CR10","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/jac\/dkq471","volume":"66","author":"O Cuevas","year":"2011","unstructured":"Cuevas, O. et al. Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, Levofloxacin and amoxicillin\/clavulanic acid. J. Antimicrob. Chemother. 66, 664\u2013669 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"16957_CR11","unstructured":"China Antimicrobial Resistance Surveillance System. CHINET 2023 surveillance of bacterial resistance in China. Available from: https:\/\/www.chinets.com\/Document\/Index?pageIndex=0#"},{"key":"16957_CR12","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.cmi.2016.01.001","volume":"22","author":"FP Hu","year":"2016","unstructured":"Hu, F. P. et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005\u20132014. Clin. Microbiol. Infect. 22, S9\u2013S14 (2016).","journal-title":"Clin. Microbiol. Infect."},{"key":"16957_CR13","unstructured":"UK Health Security Agency. English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report 2023 to 2023. Available from: https:\/\/www.gov.uk\/government\/publications\/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report\/accessible-text-versions-of-the-infographics-for-the-2020-to-2021-espaur-report"},{"key":"16957_CR14","unstructured":"Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022. [Online]. (2022). Available: https:\/\/www.who.int\/publications\/book-orders"},{"key":"16957_CR15","unstructured":"China Antimicrobial Resistance Surveillance System. CHINET 2021 surveillance of bacterial resistance in China. Available from: https:\/\/www.chinets.com\/Document\/Index?pageIndex=0#"},{"key":"16957_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s42003-023-05745-7","volume":"7","author":"J Huang","year":"2024","unstructured":"Huang, J. et al. Carbapenem-resistant Escherichia coli exhibit diverse Spatiotemporal epidemiological characteristics across the Globe. Commun. Biol. 7, 51 (2024).","journal-title":"Commun. Biol."},{"key":"16957_CR17","doi-asserted-by":"publisher","first-page":"dlaa051","DOI":"10.1093\/jacamr\/dlaa051","volume":"2","author":"P Collignon","year":"2020","unstructured":"Collignon, P. & CON, B. J. J. COVID-19 will not result in increased antimicrobial resistance prevalence. JAC Antimicrob. Resist. 2, dlaa051 (2020).","journal-title":"JAC Antimicrob. Resist."},{"key":"16957_CR18","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1093\/jac\/dkab300","volume":"76","author":"S Tomczyk","year":"2021","unstructured":"Tomczyk, S. et al. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: A global survey. J. Antimicrob. Chemother. 76, 3045\u20133048 (2021).","journal-title":"J. Antimicrob. Chemother."},{"key":"16957_CR19","doi-asserted-by":"publisher","first-page":"106183","DOI":"10.1016\/j.jinf.2024.106183","volume":"86","author":"X Yang","year":"2024","unstructured":"Yang, X. et al. Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data. J. Infect. 86, 106183 (2024).","journal-title":"J. Infect."},{"key":"16957_CR20","unstructured":"Ecdc & Antimicrobial resistance in the EU\/EEA (EARS-Net). - Annual epidemiological report for 2022. [Online]. Available: https:\/\/atlas.ecdc.europa.eu\/"},{"key":"16957_CR21","unstructured":"China Antimicrobial Resistance Surveillance System. Data of China Antimicrobial Resistance (2017\u20132023). Available from: https:\/\/www.chinets.com\/Document\/Index?pageIndex=0"},{"key":"16957_CR22","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","volume":"74","author":"PD Tamma","year":"2022","unstructured":"Tamma, P. D. et al. Infectious diseases society of America guidance on the treatment of AmpC \u03b2-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections. Clin. Infect. Dis. 74, 2089\u20132114 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"16957_CR23","doi-asserted-by":"publisher","first-page":"eCollection","DOI":"10.3389\/fcimb.2017.00055","volume":"7","author":"CR Lee","year":"2017","unstructured":"Lee, C. R. et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front. Cell. Infect. Microbiol. 7, eCollection (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"16957_CR24","doi-asserted-by":"publisher","first-page":"1900516","DOI":"10.2807\/1560-7917.ES.2020.25.34.1900516","volume":"25","author":"M Polemis","year":"2020","unstructured":"Polemis, M., Tryfinopoulou, K., Giakkoupi, P. & Vatopoulos, A. Eight-year trends in the relative isolation frequency and antimicrobial susceptibility among bloodstream isolates from Greek hospitals: data from the Greek electronic system for the surveillance of antimicrobial Resistance - WHONET-Greece, 2010 to 2017. Euro. Surveill. 25, 1900516 (2020).","journal-title":"Euro. Surveill"},{"key":"16957_CR25","doi-asserted-by":"publisher","first-page":"e0422823","DOI":"10.1128\/spectrum.04228-23","volume":"12","author":"H Kong","year":"2024","unstructured":"Kong, H. et al. Clinical risk factors and outcomes of carbapenem-resistant Escherichia coli nosocomial infections in a Chinese teaching hospital: a retrospective study from 2013 to 2020. Microbiol Spectr. 12, e0422823 (2024).","journal-title":"Microbiol Spectr"},{"key":"16957_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12879-016-2176-9","volume":"17","author":"X Meng","year":"2017","unstructured":"Meng, X. et al. Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital. BMC Infect. Dis. 17, 82 (2017).","journal-title":"BMC Infect. Dis."},{"key":"16957_CR27","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1093\/infdis\/jiz622","volume":"221","author":"X Qin","year":"2020","unstructured":"Qin, X. et al. The colonization of carbapenem-resistant Klebsiella pneumoniae: epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J. Infect. Dis. 221, S206\u2013S214 (2020).","journal-title":"J. Infect. Dis."},{"key":"16957_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13756-018-0370-9","volume":"7","author":"G Raman","year":"2018","unstructured":"Raman, G., Avendano, E. E., Chan, J., Merchant, S. & Puzniak, L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: A systematic review and meta-analysis. Antimicrob. Resist. Infect. Control. 7, 79 (2018).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"16957_CR29","first-page":"235","volume":"24","author":"Y Wiener-Well","year":"2022","unstructured":"Wiener-Well, Y. et al. Rate and risk factors for carbapenem resistant Acinetobacter baumannii clinical infections in colonized patients. Isr. Med. Assoc. J. 24, 235\u2013240 (2022).","journal-title":"Isr. Med. Assoc. J."},{"key":"16957_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-018-0301-x","volume":"18","author":"ME Ibrahim","year":"2019","unstructured":"Ibrahim, M. E. Prevalence of Acinetobacter baumannii in Saudi arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance. Ann. Clin. Microbiol. Antimicrob. 18, 1 (2019).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"16957_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","volume":"7","author":"CR Lee","year":"2017","unstructured":"Lee, C. R. et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front. Cell. Infect. Microbiol. 7, 55 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"16957_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.37201\/req\/101.2020","volume":"33","author":"VG Zafra","year":"2020","unstructured":"Zafra, V. G. et al. Risk factors for methicillin-resistant Staphylococcus aureus and extended-spectrum \u00df-lactamase-producing enterobacterales in patients with diabetic foot infections requiring hospital admission. Rev. Esp. Quimioter. 33, 430\u2013435 (2020).","journal-title":"Rev. Esp. Quimioter"},{"key":"16957_CR33","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1099\/jmm.0.001155","volume":"69","author":"D Schweitzer","year":"2020","unstructured":"Schweitzer, D. et al. Methicillin-resistant Staphylococcus aureus colonization in patients undergoing primary total hip arthroplasty. J. Med. Microbiol. 69, 600\u2013604 (2020).","journal-title":"J. Med. Microbiol."},{"key":"16957_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ijantimicag.2017.01.008","volume":"49","author":"ME Flokas","year":"2017","unstructured":"Flokas, M. E., Karageorgos, S. A., Detsis, M., Alevizakos, M. & Mylonakis, E. Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis. Int J. Antimicrob Agents. 49, 565\u2013572 (2017).","journal-title":"Int J. Antimicrob Agents"},{"key":"16957_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.33073\/pjm-2022-023","volume":"71","author":"FZ Yang","year":"2022","unstructured":"Yang, F. Z. et al. Diminished susceptibility to cefoperazone\/sulbactam and piperacillin\/tazobactam in Enterobacteriaceae due to Narrow-Spectrum \u03b2-Lactamases as well as omp mutation. Pol. J. Microbiol. 71, 251\u2013256 (2022).","journal-title":"Pol. J. Microbiol."},{"key":"16957_CR36","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12879-021-06140-5","volume":"21","author":"C Liang","year":"2021","unstructured":"Liang, C. et al. Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019. BMC Infect. Dis. 21, 444 (2021).","journal-title":"BMC Infect. Dis."},{"issue":"suppl_1","key":"16957_CR37","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","volume":"215","author":"LK Logan","year":"2017","unstructured":"Logan, L. K. & Weinstein, R. A. The epidemiology of Carbapenem-Resistant enterobacteriaceae: the impact and evolution of a global menace. J. Infect. Dis. 215 (suppl_1), S28\u2013S36 (2017).","journal-title":"J. Infect. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16957-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16957-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16957-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:12:12Z","timestamp":1757434332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16957-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16957"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16957-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the ethical standards of the Helsinki Declaration (1964, revised 2013). This study was approved by the Research Ethics Board of the First Affiliated Hospital of Chongqing Medical University (approval number: KX2024-KYC0168-01). In its resolution dated September 30, 2024, the Research Ethics Board of the First Affiliated Hospital of Chongqing Medical University granted an exemption from informed consent for this retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"31381"}}